<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Obesity | smithsonianmag.com</title><link>https://www.smithsonianmag.com/rss/tag/obesity/</link><description>RSS feed for Obesity</description><atom:link href="https://www.smithsonianmag.com/rss/tag/obesity/" rel="self"/><language>en</language><lastBuildDate>Fri, 13 Nov 2026 15:22:31 +0000</lastBuildDate><item><title>GLP-1s Are Showing Promise Beyond Weight Loss. Could They Be 'Wonder Drugs' for Ailments Like Addiction, Dementia and Cancer?</title><link>https://www.smithsonianmag.com/science-nature/glp-1s-are-showing-promise-beyond-weight-loss-could-they-be-wonder-drugs-for-ailments-like-addiction-dementia-and-cancer-180989867/</link><description>The medications seem to act on the brain’s reward circuitry and help regulate inflammation, which is why they might have so many positive effects. But research on many potential benefits is still preliminary, so clinical trials will truly put GLP-1s to the test</description><pubDate>Fri, 13 Nov 2026 15:22:31 +0000</pubDate><guid>https://www.smithsonianmag.com/science-nature/glp-1s-are-showing-promise-beyond-weight-loss-could-they-be-wonder-drugs-for-ailments-like-addiction-dementia-and-cancer-180989867/</guid><enclosure length="1089214" type="image/jpeg" url="https://th-thumbnailer.cdn-si-edu.com/0UPL0KtDK_4EBUf6egMgEChy4Bw=/420x240/filters:focal(750x500:751x501)/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/c1/d3/c1d36890-f11c-4dcc-a1c8-5de9455f5abb/smithmag-glp1s-1126.jpg"/></item></channel></rss>